GFPT2 and cancer: Nr4a1 is linked to circadian melatonin and dopamine release in the mouse retina29, diabetic retinopathy via NR4A1-dependent GFAT2 expression30, and regulation of apoptosis in hypoxic cancer tissues31,32.